Results 261 to 270 of about 475,058 (385)

Elevated rates of schizophrenia in a familial sample with mental illness and intellectual disability [PDF]

open access: green, 2004
Celia M.T. Greenwood   +4 more
openalex   +1 more source

Bioinspired Cationic Antimicrobial Polymers

open access: yesAngewandte Chemie International Edition, Accepted Article.
Antibiotics are an essential tool of modern medicine, which is critically endangered by the spread of antimicrobial resistance (AMR). Without effective antibiotics, a number of medical advancements from the last century are in jeopardy, threatening our global public health and leading to a high death toll.
Heliya Javadi   +2 more
wiley   +1 more source

Morbidity and Health‐Care Use in People with Intellectual Disabilities in General Practice: First Results of a Survey in the Netherlands [PDF]

open access: green, 2004
H. M. J. van Schrojenstein Lantman‐de Valk   +6 more
openalex   +1 more source

Bioelectronics with Topological Crosslinked Networks for Tactile Perception

open access: yesAdvanced Physics Research, EarlyView.
The recent advances in 3 different topological crosslinked networks are summarized, focusing on their assembly methods, structural characteristics, and device performance decoupling. Also, the ionic and electronic transport mechanisms, which provide insights into ionic‐electronic coupling, are elaborated.
Mingqi Ding, Pengshan Xie, Johnny C. Ho
wiley   +1 more source

Genetic variants and phenotypic data curated for the CAGI6 intellectual disability panel challenge. [PDF]

open access: yesHum Genet
Aspromonte MC   +22 more
europepmc   +1 more source

Snoezelen: Children with Intellectual Disability and Working with the Whole Family [PDF]

open access: gold, 2004
Karim Nasser   +4 more
openalex   +1 more source

Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Our objective was to evaluate the efficacy and safety of subcutaneous (SC) abatacept and standard of care (SOC) for the treatment of idiopathic inflammatory myopathy (IIM) over 52 weeks. Methods In this randomized, double‐blind, placebo‐controlled phase III trial, patients with treatment‐refractory IIM received SC abatacept (at 125 mg weekly)
Rohit Aggarwal   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy